Analyst price target range
Evogene Price Target: $2.15 Average
Direct answer
Evogene's average price target is $2.15.
The verified analyst range runs from $2.15 to $2.15.
The low target implies +299.7%, the high target implies +299.7%, and the range spans 0% of the current price.
Forecast evidence checked September 5, 2026.
Get free Evogene email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $0.54
- Average price target
- $2.15
- High price target
- $2.15
- Low price target
- $2.15
- Low target gap
- +299.7%
- Target upside
- +299.7%
- High target gap
- +299.7%
- Target range width
- 0%
- Consensus rating
- none
- Analysts
- 1
- Evidence date
- September 5, 2026
- Valid through
- September 12, 2026
Explore related company data
Read the frequently asked questions.
What is Evogene's average price target?
Evogene's verified average price target is $2.15. The target range is $2.15 to $2.15.
How far are Evogene's low and high targets from the recorded price?
The low target implies +299.7%, while the high target implies +299.7%.
How many analysts are included in Evogene's consensus?
The verified consensus includes 1 analysts.
How is Evogene's target upside or downside calculated?
The average target of $2.15 is divided by the recorded price of $0.54, then one is subtracted to produce +299.7%. This does not guarantee a future return.
When was Evogene's analyst forecast verified?
The data was verified on 2026-09-05. The dataset is valid through 2026-09-12.